The T cell-associated CD28 molecule plays a key role in T cell co-stimulation. Its ligation induces the tyrosine phosphorylation of numerous proteins including CD28 itself as well as a restricted set of substrates of 97 and 62-68 kDa which are poorly phosphorylated by the tyrosine kinases induced by CD3-TCR triggering. In this study, we identify these substrates as the product of the vav proto-oncogene and as a 62 kDa protein that could correspond at least in part to p62 dok , the 62 kDa adaptor molecule associated to p120 Ras-GTPase activating protein. Both p97 vav and p62 are tyrosine phosphorylated upon CD28 ligation by mAb or by its counter-receptor B7-1/CD80. Using CD28 mutants, we also show that Vav and p62 tyrosine phosphorylation is regulated by distinct domains within the CD28 cytoplasmic tail: residues 173-181 for Vav and residues 182-202 for p62. Finally, the phosphorylation of Vav and p62 does not require an intact binding site for Grb-2 or p85 SH2 domains. We thus demonstrate that the CD28 cytoplasmic domain contains at least three functionally independent regions involved in CD28-induced signal transduction, since in addition to the Grb-2 and p85 SH2 domain binding site (Tyr173), residues 173-181 and 182-202 are associated with Vav and p62 tyrosine phosphorylation respectively.
Introduction
CD28 is a 44 kDa homodimeric protein present on most CD4 ϩ and a proportion of CD8 ϩ T cells. The CD28 molecule is involved in T cell co-stimulation, and its triggering leads to cytokine production (1-2) and cytokine receptor expression (3), while its blockade leads to T cell unresponsiveness (4) . CD28 interacts with at least three counter-receptors, i.e. B7-1/CD80, B7-2/B70/CD86 and B7-3 (5) (6) (7) (8) (9) , that show various expression patterns on antigen-presenting cells. B7-1/CD80 is expressed on activated B cells, T cells, macrophages and dendritic cells, whereas B7-2/B70/CD86, also expressed on activated T and B cells, is constitutively present on resting monocytes (10) . The rationale for the existence of several ligands for CD28 is unknown. Some reports, however, have suggested that the interaction of CD28 with B7-1 or B7-2 can induce the differentiation of T cells towards T h 1 or T h 2 cytokine Correspondence to: D. Olive Transmitting editor: L. Moretta Received 14 November 1997, accepted 5 January 1998 production respectively (11) (12) (13) (14) . The basis of the alternative maturation programs elicited by the interaction of CD28 with B7-1 or B7-2 is not understood at present. Numerous data demonstrate that CD28 signaling induces various biochemical events associated with signal transduction. These include the tyrosine phosphorylation of substrates such as phospholipase C (PLC)γ1 (15) (16) (17) and tyrosine kinases Lck and Itk/Emt (18) (19) , as well as the activation of p21 ras and Raf-1 (20) (21) , acidic sphingomyelinase (22) (23) , JNK (24) , and phosphoinositide (PI) 3-kinase (25) (26) (27) (28) (29) (30) . Among the second messengers associated with CD28 co-stimulation only three are so far thought to be specific: p85 binding to the intracytoplasmic domain of CD28, activation of acidic sphingomyelinase and tyrosine phosphorylation of three substrates. PI 3-kinases phosphorylate the PI hydroxyl group at position 3 on the myo-inositol ring generating PI 3-phosphates [PtdIns3P, PtdIns(3,4)P2 and PtdIns (3, 4, 5) P3]. The class I PI 3-kinases consist of a regulatory 85 kDa subunit which contains one SH3 and two SH2 domains, and of a catalytic 110 kDa subunit (reviewed in 31). CD28 stimulation via either CD28 mAb or interaction with its ligands B7-1/CD80 and B7-2/CD86 induces the binding of the p85 SH2 domain to a motif (pTyr173-Met-Asn-Met) found in the CD28 intracytoplasmic domain and the subsequent activation of p110. Tyr173 phosphorylation is probably independent of Lck since CD28 still associates with p85 upon stimulation in the JCam-1 LckJurkat cell line (32) . The sphingomyelin signal transduction pathway which is coupled to lymphokine receptors and Fas is also activated upon CD28 but not CD3-TCR stimulation. Protein tyrosine kinases are critical for CD28 signaling. So far the protein tyrosine kinases found to be activated by and/or associated with CD28, i.e. Lck, Fyn and Itk/Emt, are not CD28 specific since they are also activated in response to the stimulation of the CD3-TCR complex. However, specific tyrosine phosphorylated substrates of mol. wt 110, 97 and 62-68 kDa are associated only with CD28 and not with CD3-TCR triggering. On the basis of their apparent sizes these substrates may correspond to the catalytic subunit of PI 3-kinase (p110), to Vav (p97) and to the GTPase activating protein (GAP)-associated 62 kDa protein (p62-68) (16) (17) (32) (33) . The latter molecule has recently been cloned and named p62 dok (34) (35) .
We have focused our work on identifying the p97 and p62-68 phosphorylated substrates, and investigating the structural basis for their phosphorylation. For clarity we thereafter refer to p62 as to the previously described p62-68. We demonstrate that: (i) p97 is Vav, (ii) p62 corresponds at least in part to p62 dok , the 62 kDa GAP-associated protein, (iii) phosphorylation of Vav and p62 is conserved in CD28 mutants lacking the Grb-2 and p85 SH2 domain binding site (Tyr173 replaced to Phe), and (iv) the phosphorylation of Vav and p62 is associated with two distinct regions of the CD28 cytoplasmic domain, amino acids 182-202 for p62 and amino acids 173-181 for Vav phosphorylation.
Methods

Cells
The murine T cell hybridoma DC27.1 used for transfection was provided by B. Malissen (Centre d'Immunologie, INSERM-CNRS, Marseille-Luminy, France). It has been generated by transfecting the TCR αβ genes of KB5C20 in DO11.10.2. Cells were grown in DMEM containing 10% FCS, sodium pyruvate (1 mM), β-mercaptoethanol (50 mM) and antibiotics (penicillinstreptomycin 10 IU/ml), supplemented by xanthine (250 mg/ ml), hypoxanthine (13.6 mg/ml) and mycophenolic acid (2 mg/ ml). L cells were transfected by a CD80/B7-1-containing vector to generate B7-1 L cells. Antibodies CD28.2, the mouse anti-human CD28 mAb used in this study, has already been described (36) . As an endogenous control we used a hamster anti-murine CD3ε mAb, 145-2C11. These antibodies were used for stimulation at a final concentration of 10 mg/ml. Cross-links were realised with 50 µl of polyclonal goat anti-mouse antiserum (GAM). Both anti-phosphotyrosine mAb (4G10) and affinity-purified polyclonal rabbit anti-human GAP antiserum were purchased from UBI (Lake Placid, NY). For immunoprecipitation we used an affinity-purified rabbit polyclonal anti-human Vav antiserum from Santa Cruz Biotechnology (Santa Cruz, CA) and a mouse anti-human Vav mAb from UBI for immunoblotting.
Oligonucleotide-directed mutagenesis and cell transfection
In addition to a wild-type human CD28 control transfectant (DWT6.11) we used a panel of CD28 deletion mutants (10, 21, 30 and 41 amino acids) as well as a point mutation in the CD28 intracytoplasmic domain (Tyr173 → Phe). Deletion of 10 and 21 residues (del10 and del21) were selected since they disrupted two putative Pro-rich domains found between amino acids 178-183 and 190-194 . Both the deletion of 30 residues (del30) and the point mutation of Tyr173 (dyf173) disrupted the pTyr173-Met-Asn-Met site involved in the binding of p85 and Grb-2 SH2 domains. Deletion of 41 residues (del41) corresponds to tailless CD28. CD28 mutagenesis and transfection into DC27.1 have been described elsewhere (26, 37) . Stable transfectants were selected for their resistance to 3 mg/ml geneticin G418 (Life Technology, Cergy Pontoise, France) and sorted for their similar expression of the human CD28 molecule with a cell sorter (FACS Vantage; Becton Dickinson, Mountain View, CA) (26, 37) .
Immunoprecipitation and immunoblotting
Transfected cells were removed from culture, washed and resuspended to 10 6 cells/ml in DMEM, then prewarmed at 37°C and stimulated. After centrifugation, they were lysed in buffer containing HEPES 50 mM, pH 7.5, NaF 100 mM, NaCl 150 mM, EDTA 20 mM, NP-40 1% and Na 3 VO 4 10 mM, supplemented by phosphatase and protease inhibitors. Proteins from cell lysates corresponding to 10 6 cells were resolved in 10% SDS-PAGE standard gels. For immunoprecipitation, lysates were clarified by centrifugation before a 2 h incubation at 4°C with anti-Vav or anti-GAP antibodies coupled to Protein A-Sepharose. For sequential immunoprecipitation, the first round of immunoprecipitation was followed by an incubation of the supernatants with specific antibodies coupled to Protein A-Sepharose. Immunoprecipitates were washed 3 times in 500 ml of buffer supplemented with orthovanadate and then boiled in reducing SDS gel sample buffer for 3 min. Samples were resolved by 10% SDS-PAGE standard gels. For immunoblotting, membranes were blocked and probed with specific antibodies. Blots were then incubated with the appropriate secondary antibodies: anti-rabbit IgG or anti-mouse IgG (Amersham, Les Ulis, France), all conjugated with horseradish peroxidase. Immunoreactive proteins were visualized by enhanced chemiluminescence (ECL; Amersham).
Results
Tyrosine phosphorylations induced by CD28 ligation
To analyze CD28 signal transduction pathways, wild-type CD28 molecule as well as a series of deleted and point mutated variants were expressed in a murine T cell hybridoma. Initial experiments explored the tyrosine phosphorylation profiles induced by the stimulation of transfected CD28 and of the endogenous CD3-TCR complex. DWT6.11 transfectants expressing wild-type human CD28 cDNA were stimulated with CD3 or CD28 mAb and the tyrosine phosphorylation profiles were analyzed by immunoblotting with an anti-phosphotyrosine mAb. Analysis was performed over a 60 min time course stimulation (Fig. 1A) . As previously reported the pattern and intensity of tyrosine phosphorylation induced by CD3-TCR and CD28 stimulations were different. Several tyrosine phosphoproteins were common to both stimulations although a much weaker level of phosphorylation was observed for CD28 (36-38 and 112 kDa). By contrast the level of phosphorylation of p97 and p62 was far stronger after CD28 stimulation, with no detection at all of p62 phosphorylation after CD3-TCR stimulation. Phosphorylation of p97 was not CD28 specific since it was early and transiently induced by CD3-TCR stimulation. However, in the case of a CD28 stimulation the level only decreased after 30 min and was still detectable after 1 h.
Several data have shown differences in the second messengers induced by CD28 signaling when using mAb or the CD28 ligands B7-1 and B7-2 for activation. Whilst both CD28 mAb and the CD28/B7-1 interaction efficiently induce IL-2 production, only CD28 mAb can activate p21 ras , Raf-1 and Erk, and induce Grb-2 binding to the cytoplasmic domain of CD28 (21, 38) . It was therefore important to analyze the tyrosine phosphorylation of cellular substrates induced by CD28/B7 interaction. As shown in Fig. 1 (B), p97 and p62 were the major substrates tyrosine phosphorylated upon CD28/B7-1 interaction. However, the kinetics of their phosphorylation were strikingly different. p97 phosphorylation was readily detected after 1 min of B7-1 activation and remained for at least 60 min, whereas p62 phosphorylation was a rather late event detected at 5 min and reaching a plateau at 60 min. These two major CD28-specific substrates are likely to correspond to p97 and p62 observed in Jurkat cells (17, 21, (32) (33) .
Identification of p97 and p62
Cellular substrates which are tyrosine phosphorylated upon CD28 stimulation have been detected from whole cell lysates or immunoprecipitates by immunoblotting with anti-phosphotyrosine mAb. So far PLCγ1, Lck, Fyn, Itk/Emt, Vav and p62 ras GAP-associated protein have been shown to be tyrosine phosphorylated upon CD28 stimulation (18) (19) 21, 33) , but since the biochemical characterization of the 97 and 62 kDa proteins had not been performed formally we have undertaken their identification. The two most likely candidates are Vav and the 62 kDa ras GAP-associated protein. In order to identify the 97 kDa protein, cells were stimulated by CD3 and CD28 mAb for 2 min, lysed and subjected to immunoprecipitation with an anti-Vav antiserum. Both the immunoprecipitate and the Vav-depleted lysate were analyzed by anti-phosphotyrosine ( Fig. 2A) or anti-Vav (Fig. 2B) immunoblotting. As previously reported, Vav was tyrosine phosphorylated upon CD3-TCR and CD28 stimulation ( Fig. 2A , lanes 5 and 6) with distinct intensities and kinetics; whilst CD3-induced p97 phosphorylation reaches a peak at 2 min, CD28-induced phosphorylation was still observed 30 min after stimulation (data not shown). The 97 kDa tyrosine phosphorylated substrate corresponds solely to Vav since preclearing by an antiVav antiserum depleted p97 entirely from the lysate (Fig. 2B,  lanes 8 and 9) .
A likely candidate that could correspond to the 62 kDa protein phosphorylated upon CD28 stimulation is p62 dok , the p21 ras -GAP-associated molecule. p62 dok has been shown to be tyrosine phosphorylated and associated to the SH2 domain of Grb-2 upon CD28/B7-1 and B7-2 interaction (33) . In order to further characterize the 62 kDa substrate we performed immunoprecipitation using an anti-GAP antiserum which immunoprecipitates p62 dok . We stimulated the CD28-transfected cells with CD28 mAb and subjected the lysates to two consecutive anti-GAP immunoprecipitations. Immunoprecipitates were then analyzed by anti-phosphotyrosine (Fig. 3A) and anti-GAP (Fig. 3B) immunoblotting. Upon CD28 ligation a 62 kDa tyrosine phosphorylated substrate was immunoprecipitated with GAP (Fig. 3A, lane 4) . However, the GAPassociated p62 protein corresponds only to a part of the 62 kDa band which is phosphorylated upon CD28 stimulation (Fig. 3A, compare lanes 2 and 4) . This was further confirmed by the analysis of the post-immunoprecipitation lysate where a 62 kDa tyrosine phosphorylated substrate was still strongly detected and was not depleted by two rounds of anti-GAP immunoprecipitation (Fig. 3A, lane 8) . Similar results were obtained with different samples of anti-GAP antisera (data not shown). Hence, the CD28-specific tyrosine phosphorylated p62 substrate corresponds at least in part to the p62 GAP-associated protein (p62 dok ) detected by immunoprecipitation with anti-GAP antisera.
Distinct regions of CD28 associated with p97 and p62 phosphorylation Within the 41 intracytoplasmic residues of CD28 a consensus binding site for the SH2 domains of Grb-2 and p85 (pTyr173- Met-Asn-Met) as well as two putative Pro-rich regions have been identified (Fig. 4A ). There is, however, no obvious binding site for protein tyrosine kinases although CD28 has been reported to co-precipitate with Lck, Fyn and Itk/Emt (19, 38, 18) . We have generated CD28 deletion mutants lacking 10, 21, 30 and 41 intracytoplasmic amino acids as well as a point mutation of Tyr173 (Fig. 4A) . The replacement of this residue by a Phe prevented most of the binding of the SH2 domain of p85 and Grb-2 to CD28 (26, 37) . Cells transfected by these mutant constructs were stimulated by CD3 and CD28 mAb prior to lysis and the lysates analyzed by antiphosphotyrosine immunoblotting (Fig. 4B and C) . All the mutants displayed identical profiles of tyrosine phosphorylation upon CD3 stimulation (Fig. 4B, compare lanes 2, 5, 8 , 11 and 14 with Fig. 4C, lanes 2-3, 8-9 and 14-15 ). Mutants lacking 30 and 41 amino acids did not elicit any significant tyrosine phosphorylation of cellular substrates above background upon CD28 stimulation (Fig. 4B, lanes 12 and 15; Fig.  4C, lanes 10-12) . CD28-mediated tyrosine phosphorylation of Vav was completely abolished in the mutant lacking 30 amino acids (Fig. 4B, lane 12; Fig. 4C, lanes 10-12) , whereas it was conserved in the mutants lacking 10 and 21 residues (Fig. 4B, lanes 6 and 9) . By contrast, CD28-mediated p62 phosphorylation decreased upon deletion of 10 residues and was completely abolished by the deletion of 21 amino acids (Fig. 4B, compare lanes 3, 6 and 9) .
The p85 adaptor subunit of PI 3-kinase and the Grb-2 molecule have been described to bind several proteins such as Vav, p62 GAP-associated protein and Cbl, thus forming transducing complexes that are important for receptor functions. We have therefore tested a CD28 mutant where Tyr173 has been replaced by a Phe (thus preventing most of p85 and Grb-2 binding). As shown in Fig. 4(C) , CD28 ligation still elicited the strong tyrosine phosphorylation of Vav and of 62 kDa substrates (lanes [16] [17] [18] , thus making unlikely a role for p85 or Grb-2 in CD28-induced tyrosine kinase activation.
Discussion
Ligation of CD28 by either mAb or by its ligands B7-1/CD80 and B7-2/CD86 elicits the tyrosine phosphorylation of a set of cellular substrates (16) (17) 21, 33) . Tyrosine phosphorylation is a crucial event for CD28 co-stimulatory function since tyrosine kinase inhibitors like herbimycin prevent these phosphorylations as well as IL-2 production (16) (17) . Identification of the substrates that are tyrosine phosphorylated upon CD28 ligation is thus critical for the understanding of CD28 function. Among these substrates is the CD28 intracytoplasmic domain itself since CD28-CD80 interaction induces the phosphorylation of Tyr173, thus allowing the binding of the SH2 domains of p85 and Grb-2 (26, 30, 39) . In addition, CD28 ligation has been reported to induce the specific tyrosine phosphorylation of 110, 97 and 62-68 kDa substrates which are proposed to be the catalytic subunit of PI 3-kinase, the product of the proto-oncogene vav and the p62 ras GAP-associated protein respectively (21, (32) (33) . In this report we demonstrate that p97 is indeed Vav and p62 is at least in part the p62 ras GAP-associated protein (p62 dok ). Tyrosine phosphorylation of Vav and p62 is differently regulated since CD28-B7-1 interaction-induced p62 tyrosine phosphorylation occurs later than that of Vav. We finally demonstrate that two regions in the CD28 cytoplasmic domain distinct from the p85 and Grb-2 SH2 binding site are involved in tyrosine phosphorylation suggesting a distinct regulation by tyrosine kinases.
Vav and p62 are the two major cellular substrates tyrosine phosphorylated upon CD28 stimulation vav is a proto-oncogene specifically expressed in hematopoietic and trophoblast cells. Its gene product contains a series of structural motifs including pleckstrin homology, Dbl homology, Src homology 2 (SH2) and Src homology 3 (SH3) domains, suggestive of a role in signal transduction (40) (41) . Vav is a substrate for protein tyrosine kinases since it is rapidly tyrosine phosphorylated upon activation by the T and B cell receptors. Vav plays an important role in T and B cell activation and differentiation. The injection of embryonic stem cells homozygous for a null mutation in the vav gene into blastocysts of RAG-1-or RAG-2-deficient mice impaired T and B cell proliferative responses (42) (43) (44) (45) . Finally, inhibition of NF-AT function is observed together with a deficient CD3-TCR cap formation in vav -/-mice (G. Crabtree, pers. commun.). As shown in this report, CD28-and CD3-induced Vav tyrosine phosphorylation occurs early after activation. In contrast to CD3, CD28-mediated Vav phosphorylation is long lasting since it is still detected after 30 min of stimulation. The strong and persistent tyrosine phosphorylation of Vav by CD28 explains why Vav was previously considered as a specific substrate of the CD28 co-stimulatory pathway. Furthermore, these data suggest differential regulation of Vav tyrosine phosphorylation/dephosphorylation upon stimulation by CD3-TCR and CD28.
p120 Ras-GAP is a negative regulator of p21 ras . Two proteins of 62 and 190 kDa (Rho-GAP) which are phosphorylated on tyrosine residues are associated to p120 Ras-GAP. Association of p120 GAP with p62 and p190 Rho-GAP is dependent on the activation of tyrosine kinases such as Lck, Src or Abl (46) (47) (48) . In addition, various cell stimuli induce the tyrosine phosphorylation of the p62 GAP-associated protein such as the stimulation of the adhesion molecules CD2 and CD28 but not that of CD3-TCR in T lymphocytes (49, 33) . p62 GAP-associated protein, p62 dok , was recently cloned (34) (35) and shown to contain multiple domains involved in proteinprotein interaction such as a putative pleckstrin homology domain at its extreme N-terminus as well as 10 Pro-X-X-Pro motifs. Moreover, a number of tyrosine residues are present in its carboxy-terminal half and are likely to be substrates for protein tyrosine kinases. These domains may account for its binding to Src-family kinases, PLCγ and Csk. Hence, CD28 seems to regulate the tyrosine phosphorylation of this adaptor molecule which is not tyrosine phosphorylated upon CD3-TCR signaling and is likely to be an important effector of the CD28 pathway. On the basis of our immunoprecipitation data using anti-GAP antisera we can conclude that p62 GAPassociated protein contributes at least in part to the CD28-induced 62 kDa phosphorylated substrate. The remaining 62 kDa band may correspond to other protein(s) of the same mol. wt which are also tyrosine phosphorylated upon CD28 stimulation. Alternatively, it might correspond to a different pool of the very same p62 which is tyrosine phosphorylated but does not associate with GAP. In agreement with this hypothesis Bouton et al. have shown that only 15-25% of p62 is complexed to GAP in v-src-transfected cells (50) .
Tyrosine phosphorylation of Vav and p62 could be involved in CD28 co-stimulatory function Several arguments make likely a role for the tyrosine phosphorylation of Vav and p62 in the co-stimulatory function of CD28. Regarding Vav, although its activation is not strictly CD28 specific, CD28 induces its prolonged phosphorylation which might relay a CD3-induced initial signal. The pathway elicited by Vav has not been completely identified but is in part distinct from the Ras pathway. Like Dbl, Vav mediates the transformation of fibroblasts via a mitogen-activated protein kinase pathway distinct from that activated by oncogenic ras (51) . These two pathways are, however, complementary since p21 ras and Vav activation can cooperate to transform rodent fibroblasts (52) . Accordingly, CD28-B7 interaction is a strong inducer of Vav tyrosine phosphorylation but does not induce the activation of Ras whereas CD3 signaling does (21) . The function of Vav can be blocked by FK506, suggesting that its activity depends on calcineurin (45) . Thus Vav activation cannot explain all of the co-stimulatory function of CD28 which is partially resistant to cyclosporin A and FK506. Vav is likely to be an exchange factor for Rho and Rac (53) . Several publications have demonstrated a link between Vav, the small G proteins Rho, Rac and Cdc42, and the activation of JNK (53) (54) (55) (56) . These results are important since JNK, but not Erk, seems to be involved in signal integration during costimulation of T lymphocytes (24) . p62 and Vav act at multiple levels of the transduction cascade: at the membrane level via their adaptor and exchange factor functions but also in the nucleus where they could play a dual role. In addition to its role in regulating NFAT (45) , Vav is involved in the regulation of transcription since it interacts with transcriptional regulators such as ENX-1 (57) and nuclear protein , and also in the regulation of the late steps of RNA biogenesis by modulating the function of ribonucleoproteins. This level of regulation could be important for CD28 co-stimulatory function since the regulation of cytokine receptor expression is due to the stabilization of their mRNA via as yet unidentified mechanisms which do not seem to rely only on the AU-rich sequence present in their 3Ј untranslated regions (1) (2) (3) . In addition, we have already shown that deletion of the 10 most C-terminal amino acids of CD28 abrogated IL-2 production in murine T cell hybridomas stimulated by CD28 (37) . Deletion of these residues also impaired p62 phosphorylation which could account-at least in this model-for the loss of IL-2 production. Since the co-stimulation of IL-2 production by CD28 is so far its major function it is important to understand the role played by each individual intracytoplasmic region of CD28 in its costimulatory function. The role of the other regions is not yet understood but they could be involved in the regulation of other cytokine production and cytokine receptor expression as well as in the prevention of apoptosis which are some of the other important functions of CD28 (reviewed in 59).
Identification of two distinct regions of CD28 intracytoplasmic tail involved in the tyrosine phosphorylation of Vav and p62 Two putative binding sites for SH2 and SH3 domains are present within the 41 intracytoplasmic residues of CD28 and likely play a role in transduction. In addition to the pTyr173-Met-Asn-Met motif which corresponds to the binding site for the SH2 domains of p85 and Grb-2, two stretches containing Pro residues (Pro178-Arg-Arg-Pro181 and Pro190-Tyr-AlaPro-Pro194) are present. These motifs are involved in the binding of Grb-2, presumably via its SH3 domain (39) , and may also bind SH3 domains of other adaptor molecules or protein tyrosine kinases. In addition, p85 and/or Grb-2 when bound to CD28 may, via their own SH2, SH3 and Pro-rich motifs, provide additional binding sites for other transducing molecules.
The protein tyrosine kinase Lck seems to be critical for the tyrosine phosphorylation of Vav and p62. TCR ligation of an Lck-deficient Jurkat mutant, JCaM1, with anti-CD3 mAb fails to induce the tyrosine phosphorylation of cellular substrates including Vav (60) . Using the same cell mutant, Lu et al. showed that CD28 was unable to induce the phosphorylation of the p97 substrate which is likely to be Vav as well as the phosphorylation of p62 (32) . In addition Vav co-precipitates with Lck (60) and is phosphorylated by Lck and Fyn (53) , and p62 was demonstrated to be tyrosine phosphorylated by v-Src, Abl and Lck (61, (46) (47) (48) . Taken together these studies suggest that multiple tyrosine kinases including Lck may be involved in the phosphorylation of Vav and p62. In T cells, Lck is a likely candidate for the CD28-induced phosphorylation of Vav and p62 which could be further argued by the demonstration that Lck is activated and co-precipitated with CD28 upon CD28 ligation (19, 38) . King et al. demonstrated that point mutation of Tyr173 as well as deletion of the 16 last C-terminal amino acids did not alter Lck activation, whereas a truncation of 35 amino acids prevented it. In addition they showed that mutation of Tyr173 impaired Itk/Emt activation and that deletion of 35 amino acids completely abrogated it (62) . Taken together these data demonstrate that several kinases are activated upon CD28 cross-linking and that their activation can be induced by distinct CD28 regions. We have confirmed that deletion of 10 amino acids does not prevent Lck binding to CD28 (data not shown) indicating that this kinase does not have a direct role in the regulation of p62 phosphorylation. Lck could either phosphorylate p62 and p97 directly or be an upstream effector acting by regulating a protein tyrosine kinase of the Syk family such as ZAP-70 as was previously proposed (63) . The Tec family kinase Itk/Emt is another possible candidate since it is activated early upon CD28 signaling, even before Vav tyrosine phosphorylation, although this kinase can also be activated by CD3-TCR signaling (18) . CD28-mediated Vav tyrosine phosphorylation is lost upon the truncation of the last 30 amino acids of the receptor which deletes the Tyr173-Met-Asn-Met site together with the Pro-rich motifs (Fig. 4B) . It is unlikely that the adaptors p85 and Grb-2 play a role in Vav phosphorylation since the replacement of Tyr173 with Phe does not inhibit Vav tyrosine phosphorylation (Fig. 4C) while it does prevent most of p85 and/or Grb-2 binding. A likely consequence of this deletion could be to prevent Lck association. Finally, the demonstration that the tyrosine phosphorylation of p62 is impaired by a deletion of 10 amino acids and completely lost after deletion of 21 amino acids (Fig. 4B ) does not correlate with the hypothesis that Lck is the only kinase involved in the phosphorylation of these substrates. p62 tyrosine phosphorylation is likely to depend on the recruitment and activation of other tyrosine kinases which are dependent on Lck such as ZAP-70. This hypothesis is further supported by the observation that CD28 mediates the rapid tyrosine phosphorylation of Vav, as early as 1 min after CD28/B7-1 interaction, whilst p62 phosphorylation is only detected from 5 min after stimulation (Fig. 1B) . Hence, we can propose a scheme (Fig. 5) whereby upon ligand interaction CD28 would recruit PI 3-kinase and Grb-2 and induce Vav tyrosine phosphorylation. p62 would then be phosphorylated, allowing the recruitment of other effector molecules via its adaptor domains. In conclusion, at least three intracytoplasmic regions of CD28 can be identified that are involved in signaling: a motif involved in p85 and Grb-2 SH2 domain binding and two other regions which are associated to pathways likely to be candidates for CD28 costimulatory function. Taken together, these events may sustain the biochemical events required for efficient T cell activation.
